ALKS vs TLRY · P/E 14, rev $1.56B vs rev $821.3M
Alkermes Plc (ALKS) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the ALKS and TLRY stock pages for the full models.
Not investment advice.